Cellectis (CLLS) Other Non-Current Assets (2014 - 2026)

Cellectis (CLLS) recorded quarterly Other Non-Current Assets of $21.3 million in Q1 2026, up 6.3% quarter-over-quarter from $20.0 million in Q4 2025, and up 58.34% on a YoY basis from $13.4 million in Q1 2025.

Cellectis (CLLS) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Cellectis' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $21.3 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 58.34% year-over-year to $21.3 million; the TTM figure through Mar 2026 stood at $21.3 million (up 58.34% YoY), while the FY2025 annual figure was $20.0 million, up 72.72% from the prior year.
  • Other Non-Current Assets was $21.3 million for Q1 2026 at Cellectis, up from $20.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $21.3 million in Q1 2026 to a low of $175000.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $13.5 million across 5 years, with a median of $13.4 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets tumbled 99.21% in 2022, then soared 11405.71% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $8.8 million in 2022, then decreased by 10.67% to $7.9 million in 2023, then soared by 47.64% to $11.6 million in 2024, then jumped by 72.72% to $20.0 million in 2025, then advanced by 6.3% to $21.3 million in 2026.
  • The last three Other Non-Current Assets figures came in at $21.3 million (Q1 2026), $20.0 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cellectis 17.40 Bn 17.21 Bn - 21.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.29 Mn
Dec 31, 2025 20.03 Mn
Sep 30, 2025 18.18 Mn
Jun 30, 2025 16.13 Mn
Mar 31, 2025 13.44 Mn
Dec 31, 2024 11.59 Mn
Sep 30, 2024 11.12 Mn
Dec 31, 2023 7.85 Mn
Mar 31, 2023 20.14 Mn
Dec 31, 2022 8.79 Mn
Mar 31, 2022 175,000.00
Dec 31, 2021 6.52 Mn
Sep 30, 2021 22.05 Mn
Jun 30, 2021 22.10 Mn
Mar 31, 2021 22.11 Mn
Dec 31, 2020 7.01 Mn
Sep 30, 2020 9.78 Mn
Jun 30, 2020 7.38 Mn
Mar 31, 2020 7.48 Mn
Dec 31, 2019 5.52 Mn